Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Somatosensory Stimulation for Unilateral Neglect After Stroke

Official title: Mobilization and Tactile Stimulation (MTS) to Improve Unilateral Neglect Post Stroke: a Pilot and Feasibility Study

Run by Keele University · NCT07589855 · Data updated 2026-11-12

This study tests if Mobilization and tactile Stimulation (MTS) at home can help people with unilateral neglect after a stroke who are at least 20 weeks post-stroke.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment6 (estimated)
SponsorKeele University
Academic / other
Locations1 site (Newcastle-under-Lyme)
StatusRecruiting
StartedOctober 20, 2025
Main results expectedJuly 1, 2026
Study endsJuly 1, 2026
Registry record updatedMay 15, 2026
Trial IDNCT07589855 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with unilateral neglect more than 20 weeks after stroke, able to consent, and with a caregiver to assist at home.

Probably not a fit

Individuals without ongoing caregiver support or with severe communication or cognitive barriers may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study explores whether a hands-on physical therapy technique called Mobilization and Tactile Stimulation (MTS) can improve neglect symptoms and upper limb function in adults with stroke. It uses a mixed-methods, single-subject design to observe changes before, during, and after MTS, complemented by qualitative feedback. Participants must have unilateral neglect, be at least 20 weeks post-stroke, and have a caregiver available to assist with home-based therapy over about three months. The study will document feasibility, acceptability, and potential signals of benefit using existing clinical observations and planned outcome measures. The approach builds on routine therapy for the affected arm, focusing on somatosensory input through touch, proprioception, and manual techniques.

Why it matters

Potential benefit: If successful, participants may experience improved attention to the affected side and better upper limb function after stroke.

How similar studies have gone: There is limited formal evidence on MTS for unilateral neglect, making this a relatively novel feasibility study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (≥18 years of age) who is an Adult stroke survivors (≥18 years of age) with a clinical diagnosis of UN, in the subacute-chronic phase of stroke (≥20 weeks post stroke)
* Ability to consent to participate in the study, assessed by their understanding of the study when it is explained to them.
* Sufficient cognitive and physical ability to allow inclusion in this study, assessed by the ability to follow a simple one-stage command with the non-paretic limb.
* Able and willing to receive and engage with regular therapy (MTS) (e.g. at home).

Exclusion Criteria:

* Stroke survivor with major communication problems (e.g receptive aphasia) that affect their understanding of the treatment, their ability to follow instruction, or ability to consent to participate.
* Participants who do not speak/understand English and who do not have access to an interpreter.

Where it's running

  • Midlands Partnership University NHS Foundation Trust
    Newcastle-under-Lyme, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.